NCT00277199View on ClinicalTrials.gov

Comparability DE vs CD-CHO1

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions
Healthy Subjects
Interventions
DRUG

Abatacept

Trial Locations (1)

Unknown

Inveresk Clinical Research, Edinburgh

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY